P3 Health Partners (PIII) Stock Statistics & Valuation Metrics

P3 Health Partners has a market cap or net worth of $29.68M. The enterprise value is $374.70M.

Market Cap

$29.68M

Enterprise Value

$374.70M

P3 Health Partners has 4,015,604 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

4,015,604

Owned by Insiders

18.17%

Owned by Institutions

1.64%

P3 Health Partners’s return on equity (ROE) is 0.95 and return on invested capital (ROIC) is -172.80%.

Return on Equity (ROE)

0.95

Return on Assets (ROA)

-0.23

Return on Invested Capital (ROIC)

-172.80%

Return on Capital Employed (ROCE)

-2.43

Revenue Per Employee

4.56M

Profits Per Employee

-462.34K

Employee Count

320

Asset Turnover

2.22

Inventory Turnover

0.00

The current PE Ratio of P3 Health Partners is -0.12. P3 Health Partners’s PEG ratio is -0.00.

PE Ratio

-0.12

PS Ratio

0.01

PB Ratio

0.19

Price to FCF

-0.10

Price to Operating Cash Flow

-0.10

PEG Ratio

-0.00

In the last 12 months, P3 Health Partners had revenue of 1.46B and earned -147.95M in profits. Earnings per share was -45.26.

Revenue

1.46B

Gross Profit

-144.32M

Operating Income

-270.30M

Pretax Income

-321.06M

Net Income

-147.95M

EBITDA

-181.86M

Earnings Per Share (EPS)

-45.26

In the last 12 months, operating cash flow was -130.52M and capital expenditures 0, giving a free cash flow of -130.40M billion.

Operating Cash Flow

-130.52M

Free Cash Flow

-130.40M

Free Cash Flow per Share

-38.79

P3 Health Partners pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-987.72%

Earnings Yield

-726.55%

Beta

0.06

52-Week Price Change

-53.94%

50-Day Moving Average

6.84

200-Day Moving Average

6.61

Relative Strength Index (RSI)

32.19

Average Volume (3m)

32.38K

P3 Health Partners upcoming earnings date is Nov 09, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 10, 2026

Next Earnings Date

Nov 09, 2026

Ex-Dividend Date

―

P3 Health Partners as a current ratio of 0.24, with Debt / Equity ratio of -183.52%

Current Ratio

0.24

Quick Ratio

0.24

Debt to Market Cap

23.96

Net Debt to EBITDA

-1.43

Interest Coverage Ratio

-4.91

In the past 12 months, P3 Health Partners has paid 2.02M in taxes.

Income Tax

2.02M

Effective Tax Rate

-0.01

P3 Health Partners EV to EBITDA ratio is -1.48, with an EV/FCF ratio of -0.94.

EV to Sales

0.08

EV to EBITDA

-1.48

EV to Free Cash Flow

-0.94

EV to Operating Cash Flow

-0.94

P3 Health Partners has $21.27M in cash and marketable securities with $130.27M in debt, giving a net cash position of -$109.00M billion.

Cash & Marketable Securities

$21.27M

Total Debt

$130.27M

Net Cash

-$109.00M

Net Cash Per Share

-$27.14

Tangible Book Value Per Share

-$112.79

Gross margin is 31.65%, with operating margin of -9.89%, and net profit margin of -6.55%.

Gross Margin

31.65%

Operating Margin

-9.89%

Pretax Margin

-15.12%

Net Profit Margin

-6.55%

EBITDA Margin

-5.48%

EBIT Margin

-11.08%

The average price target for P3 Health Partners is $18.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$18.00

Price Target Upside

346.65% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

2.81%

EPS Growth Forecast

26.63%

Smart Score

―

AI Score

48